Orient Biotech(SH:688298) Xin Lang Cai Jing·2025-10-31 02:13Group 1 - Oriental Bio (688298.SH) reported its Q3 2025 results on October 31, 2025, with a total of 7 institutional investors holding A-shares, amounting to 104 million shares, which represents 51.44% of the total share capital [1] - The institutional investors include companies such as Anji Fulanglai Import and Export Trade Co., Ltd., Fangs Holdings Limited Liability Company, and several funds from China Industrial Bank and China Merchants Bank [1] - Compared to the previous quarter, the total institutional holding percentage decreased by 1.23 percentage points [1] Group 2 - In the public fund sector, one fund, the Medical Device ETF, increased its holdings by 0.21% compared to the previous period [2] - One fund, the Rongtong Health Industry Flexible Allocation Mixed A/B, reduced its holdings by 0.84% compared to the previous quarter [2] - A total of 63 public funds did not disclose their holdings this period, including funds like Yuanxin Yongfeng Ju You A and Rongtong Value Growth Mixed A [2]